https://buff.ly/3zdzsWj | Join @American Conference Institute for their 4th Annual Proficiency Series on Hatch-Waxman and BPCIA from October 8-24, 2024! Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials, a critical competency for legal and business professionals in the biopharmaceutical arena. Save 10% with promo code D10-999-PM25 #HatchWaxman #BPCIA #ACIConferences
PM360 Magazine’s Post
More Relevant Posts
-
How does the Inflation Reduction Act (IRA) redefine compliance requirements for biopharmaceutical companies? In this Xtalks webinar, our experts Tiffany M. and Peter Yixiao Zou, Ph.D. will explore the IRA regulation changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access. Register here: https://lnkd.in/gSQcFr8R #SyneosHealth
-
-
In this Q&A, Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a critical role in the success of a biologic when embarking upon the commercial manufacturing journey. https://ow.ly/Sn6R50QeCOR
Embarking Upon the Commercial Manufacturing Journey For a Biologic: Strategies to Achieve Successful Approval & Launch
https://biologics.catalent.com
-
Initiating clinical studies can be challenging and even more so when you are a small or new biotech. Turn to Catalent Biologics, a trusted sterile fill/finish partner for an efficient orchestration of your project with the right scale for your Phase 1 and 2 needs. Learn more here: https://ow.ly/CXc250Sy7E8 #PharmaceuticalManufacturing #DrugDevelopment #CDMOServices #sterileinjectables https://bit.ly/4dpBTUM
-
-
Senior Consultant - Pharma R&D Advisory| Enabling Innovation and digital transformation to accelerate drug delivery
An interesting webinar to understand impact of #inflation reduction act on Pharma industry. Do join if you are interested for market acess insight and actionable solutiona from SMEs #IRA #biopharma #lifesciences #marketacess
How does the Inflation Reduction Act (IRA) redefine compliance requirements for biopharmaceutical companies? In this Xtalks webinar, our experts Tiffany M. and Peter Yixiao Zou, Ph.D. will explore the IRA regulation changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access. Register here: https://lnkd.in/gSQcFr8R #SyneosHealth
-
-
Initiating clinical studies can be challenging and even more so when you are a small or new biotech. Turn to Catalent Biologics, a trusted sterile fill/finish partner for an efficient orchestration of your project with the right scale for your Phase 1 and 2 needs. Learn more here: https://ow.ly/CXc250Sy7E8 #PharmaceuticalManufacturing #DrugDevelopment #CDMOServices #sterileinjectables https://dy.si/myxw4S
-
-
In this Q&A, Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a critical role in the success of a biologic when embarking upon the commercial manufacturing journey. https://ow.ly/Sn6R50QeCOR
Embarking Upon the Commercial Manufacturing Journey For a Biologic: Strategies to Achieve Successful Approval & Launch
https://biologics.catalent.com
-
How does the Inflation Reduction Act (IRA) redefine compliance requirements for biopharmaceutical companies? In this XTalks webinar, our experts Tiffany McCaslin and Peter Zou will explore the IRA regulation changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access. Register here: https://ow.ly/3E5y30sFbon #SyneosHealth
-
-
How does the Inflation Reduction Act (IRA) redefine compliance requirements for biopharmaceutical companies? In this XTalks webinar, our experts Tiffany McCaslin and Peter Zou will explore the IRA regulation changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access. Register here: https://ow.ly/khhP30sF5fB #SyneosHealth
-
-
In this Q&A, Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a critical role in the success of a biologic when embarking upon the commercial manufacturing journey. https://ow.ly/Sn6R50QeCOR
Embarking Upon the Commercial Manufacturing Journey For a Biologic: Strategies to Achieve Successful Approval & Launch
https://biologics.catalent.com
-
How does the Inflation Reduction Act (IRA) redefine compliance requirements for biopharmaceutical companies? In this XTalks webinar, our experts Tiffany McCaslin and Peter Zou will explore the IRA regulation changes, the scope of data requirement, and the strategic implications on drug development, pricing and market access. Register here: https://ow.ly/66wY30sFcvk #SyneosHealth
-
